Improving Our Public Health Infrastructure| EVP & Chief Patient Officer, Merck, Dr. Julie Gerberding

Improving Our Public Health Infrastructure| EVP & Chief Patient Officer, Merck, Dr. Julie GerberdingПодробнее

Improving Our Public Health Infrastructure| EVP & Chief Patient Officer, Merck, Dr. Julie Gerberding

We Unified to Accelerate Results | Dr. Julie Gerberding, EVP and Chief Patient Officer, MerckПодробнее

We Unified to Accelerate Results | Dr. Julie Gerberding, EVP and Chief Patient Officer, Merck

2018 HBA Woman of the Year Dr. Julie GerberdingПодробнее

2018 HBA Woman of the Year Dr. Julie Gerberding

Julie Gerberding: Why we're in a perfect storm for patient centric changeПодробнее

Julie Gerberding: Why we're in a perfect storm for patient centric change

Merck Chief Patient Office: Think like SARS and go viralПодробнее

Merck Chief Patient Office: Think like SARS and go viral

CDC Budget Strategy | Dr. Julie Gerberding, EVP and Chief Patient Officer, MerckПодробнее

CDC Budget Strategy | Dr. Julie Gerberding, EVP and Chief Patient Officer, Merck

The Future of Biosecurity | EVP & Chief Patient Officer, Merck, Dr. Julie GerberdingПодробнее

The Future of Biosecurity | EVP & Chief Patient Officer, Merck, Dr. Julie Gerberding

Julie Gerberding: Pharma needs to stand strongerПодробнее

Julie Gerberding: Pharma needs to stand stronger

Dr. Julie Gerberding: Pandemic Preparedness – Products, Platforms, and PartnershipПодробнее

Dr. Julie Gerberding: Pandemic Preparedness – Products, Platforms, and Partnership

Entrepreneurship Speaker Series - Julie Gerberding, Executive VP & Chief Patient Officer, MerckПодробнее

Entrepreneurship Speaker Series - Julie Gerberding, Executive VP & Chief Patient Officer, Merck

Julie Gerberding: The link between patient-centricity and commercial successПодробнее

Julie Gerberding: The link between patient-centricity and commercial success

NEJM Interview: Dr. Julie Gerberding on the past half-century of vaccine development and policy.Подробнее

NEJM Interview: Dr. Julie Gerberding on the past half-century of vaccine development and policy.

What Gives Successful Leaders Their Competitive Edge | Julie Gerberding, M.D., MerckПодробнее

What Gives Successful Leaders Their Competitive Edge | Julie Gerberding, M.D., Merck

Leadership is a Privilege | EVP & Chief Patient Officer, Merck, Dr. Julie GerberdingПодробнее

Leadership is a Privilege | EVP & Chief Patient Officer, Merck, Dr. Julie Gerberding

Merck EVP: "To be trusted, we need to show we are 'walking the talk'"Подробнее

Merck EVP: 'To be trusted, we need to show we are 'walking the talk''

CHIP Landmark Ideas Seminar - Dr. Julie GerberdingПодробнее

CHIP Landmark Ideas Seminar - Dr. Julie Gerberding

We need the entire public health system in order to bring the CDC into the next generationПодробнее

We need the entire public health system in order to bring the CDC into the next generation

Dr. Julie L. Gerberding: Health Protection PrioritiesПодробнее

Dr. Julie L. Gerberding: Health Protection Priorities

The Health Trust: Five Year Initiatives - Dr. Julie GerberdingПодробнее

The Health Trust: Five Year Initiatives - Dr. Julie Gerberding

Merck EVP: The future lies in "Value of care"Подробнее

Merck EVP: The future lies in 'Value of care'